Medicare Tech

## MedicaRetec Leads the Way in Improving Quality of Life with the Launch of 'YOMag', an Innovative Male Urinary Incontinence Clamp MedicaRetec, a startup specializing in medical devices, is drawing attention from the medical community with the introduction of 'YOMag', an innovative clamp for men suffering from urinary incontinence. This medical device significantly improves user convenience by dramatically alleviating the discomfort of existing products, and has received Grade 1 approval from the Ministry of Food and Drug Safety (MFDS) in Korea, certifying its safety and efficacy. 'YOMag' is garnering anticipation as a new alternative to relieve discomfort in daily life and help users regain confidence. Established based on advanced technology investment from KIST (Korea Institute of Science and Technology), MedicaRetec is an innovative company specializing in the development of medical devices for surgery and treatment. The company is steadily fulfilling its vision to enter the global market by successfully developing various innovative products that will lead future medicine, such as endoscopic surgical devices and real-time pneumothorax diagnosis devices. MedicaRetec has recently demonstrated its potential and technological prowess on the international stage. It achieved remarkable success by participating in BioJapan 2024 and winning a silver prize at the 2024 Taiwan Innotech Expo, and has confirmed its participation in the CES Seoul Integrated Pavilion at CES 2025, the world's largest consumer electronics show, drawing significant attention from global buyers. Through active export consultations at these international exhibitions, MedicaRetec is successfully expanding opportunities for building overseas partnerships and entering the global market. A MedicaRetec official stated, "'YOMag's launch will contribute to many men reducing discomfort in their daily lives and leading more active lives," emphasizing, "Through continuous R&D and innovation, we will further strengthen our competitiveness in the global medical device market and strive to become a company that contributes to improving human health." Meanwhile, MedicaRetec has been selected for an R&D project under the Startup Growth Technology Development Program, carrying out technology development with Seoul Technopark, thereby securing a solid foundation for continuous growth and innovation.